FDA product code QRA: Virtual Reality Behavioral Therapy Device For Pain Relief
QRA is the FDA product code for virtual reality behavioral therapy device for pain relief. It is a Class II device, regulated under 21 CFR 890.5800 and reviewed by the Physical Medicine panel. FDA has cleared 5 510(k) submissions under QRA, 5 in the last five years, from 3 different applicants. The average 510(k) review took 128 days (median 116); 78 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for QRA devices, 1 initiated in the last five years.
Definition
A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display which utilizes a software program containing the behavioral therapy content.
Classification
| Field | Value |
|---|---|
| Device name | Virtual Reality Behavioral Therapy Device For Pain Relief |
| Device class | Class II |
| Regulation | 21 CFR 890.5800 |
| Review panel | PM — Physical Medicine |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
510(k) clearances per year for QRA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2023 | 2 | 203 |
| 2024 | 1 | 30 |
| 2025 | 1 | 89 |
| 2026 | 1 | 116 |
Compare with all 510(k) review times · Search every QRA clearance
Top QRA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Cognifisense, Inc. | 2 | 2026-04-10 |
| Appliedvr | 2 | 2025-08-13 |
| Smileyscope Holding, Inc. | 1 | 2023-09-25 |
Most recent QRA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K254004 | Cognifisense, Inc. | VRNT | 2026-04-10 | 116 |
| K251519 | Appliedvr | RelieVRx (Pico G3) | 2025-08-13 | 89 |
| K243417 | Appliedvr | RelieVRx | 2024-12-04 | 30 |
| K230814 | Cognifisense, Inc. | VRNT | 2023-10-31 | 221 |
| K230825 | Smileyscope Holding, Inc. | Smileyscope System (Therapy Mode) | 2023-09-25 | 185 |
Recalls for QRA devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 0 still open. Most recent: 2023-02-27.
| Year | Recalls |
|---|---|
| 2023 | 1 |
Frequently asked questions
What is FDA product code QRA?
QRA is the FDA product code for virtual reality behavioral therapy device for pain relief. It is a Class II device, regulated under 21 CFR 890.5800 and reviewed by the Physical Medicine panel.
What device class is QRA?
Class II, regulation 21 CFR 890.5800. Typical premarket route: 510(k).
How long does a 510(k) take for product code QRA?
Across 5 cleared submissions the average was 128 days from receipt to decision (median 116).
Which companies have the most QRA clearances?
Cognifisense, Inc. (2); Appliedvr (2); Smileyscope Holding, Inc. (1).
Have QRA devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2023-02-27.
Next steps
- Run an FDA pathway report with predicate devices for product code QRA
- Run a recall and safety report across every QRA manufacturer
- Watch product code QRA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Physical Medicine product codes · FDA product code lookup · 510(k) database search · 510(k) review times